02Dec

Manage Waste Medicines & Ensure Compliance  

 

Now available from Alpha Laboratories is the Safer Options range of Controlled Drug Denature Kits which can help you safely manage waste medicines and comply with legislation more easily and effectively. 
 
Manufactured in the UK, these denature kits are simple and easy to use. Waste medicines – tablets, liquids, patches etc. are placed in the jar with the water-soluble sachet of denaturing formula. Water is then added to the designated level and the jar closed and shaken to mix the denaturing formula with the water and controlled drugs.
 
The denaturing formula congeals and denatures the drugs in a couple of minutes and the kit can then be placed in a secure pharmaceutical waste container prior to incineration. The denaturing formula has a bitter taste as an additional deterrent and is contained in a sachet to protect against spillage.  Full instructions appear on every container so there is no pack insert to get lost, especially when splitting up multipacks for use in separate locations.
 
Under the Misuse of Drugs Regulations (2001) obsolete controlled drugs (CDs) must be destroyed by being denatured and rendered irretrievable before being placed into pharmaceutical waste containers.  These new controlled drugs denature kits are an innovative and unique solution helping hospitals, pharmacies, hospices, care homes and other healthcare providers to safely manage waste medicines and comply with this legislation. 
 
The kits are available in six container volumes and a range of pack sizes providing multiple options to suit your working needs.
 
Please visit www.alphalabs.co.uk/denaturekits for further information or contact Alpha Laboratories on 0800 38 77 32 or email marketing@alphalabs.co.uk  

Related

New Partnership for Biological Sample Transport Solutions

Specialist Laboratory and Diagnostics supply company Alpha Laboratories Ltd. (Eastleigh, UK) is deli...

Read More >

SpeeDx receives CE-IVD mark for multiplex PlexPCR® VHS test for VZV, herpes and syphilis

SYDNEY, AUSTRALIA–(October 25, 2017). SpeeDx Pty. Ltd. has announced that it has received CE-IVD ma...

Read More >

New Multiplex Real-time PCR Kits Detect Clinically Relevant β-lactamase Genes

β-lactamase enzymes inactivate β-lactam antibiotics and render them ineffective for the treatment ...

Read More >

Cytox appoints new CCO

Oxford and Manchester, UK – Cytox, a precision medicine company focused on developing solutions to ...

Read More >

NEW TEST COULD REVOLUTIONISE THE DIAGNOSIS OF ‘SUPERBUGS’

A new exhibition at the Science Museum, London will feature an invention from the Oxford area which ...

Read More >

FIRST IVDR CERTIFICATE ISSUED BY TÜV SÜD

TÜV SÜD Product Service has issued their first In Vitro Medical Device Regulation (IVDR) certificate...

Read More >